Evidence map›Paper›PMID 30549411›Full record

ArticleBrain and behavior2019

Gene mutations in a Han Chinese Alzheimer's disease cohort.

Limin Ma, Jiewen Zhang, Yingying Shi, Wan Wang, Zhixia Ren, Mingrong Xia, Yuanxing Zhang, Miaomiao Yang

Open access · goldAbstract read
In one paragraph

Article in Brain and behavior, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. The Genetics of Alzheimer's Disease in the Chinese Population.International journal of molecular sciences · 2020
    Review
  6. Article
  7. International journal of molecular sciences · 2019
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Limin MaDepartment of Neurology, People's Hospital of Zhengzhou University, Zhengzhou, China.ORCID 0000-0003-4227-3245
Jiewen ZhangDepartment of Neurology, Henan Provincial People's Hospital, Zhengzhou, China.
Yingying ShiDepartment of Neurology, Henan Provincial People's Hospital, Zhengzhou, China.
Wan WangDepartment of Neurology, Xinxiang Medical University, Xinxiang, China.
Zhixia RenDepartment of Neurology, Henan Provincial People's Hospital, Zhengzhou, China.
Mingrong XiaDepartment of Neurology, Henan Provincial People's Hospital, Zhengzhou, China.
Yuanxing ZhangDepartment of Neurology, People's Hospital of Zhengzhou University, Zhengzhou, China.
Miaomiao YangDepartment of Neurology, Xinxiang Medical University, Xinxiang, China.
Henan Provincial People's Hospital · CNXinxiang Medical University · CNZhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveAlzheimer's disease (AD) is the most common form of dementia characterized by memory loss at disease onset. The gene mutations in the amyloid precursor protein (APP), presenilin 1 (PSEN1), and presenilin 2 (PSEN2) are the frequent causes of AD. However, the clinical and genetic features of AD overlap with other neurodegenerative diseases. The present study aimed to identify the clinical and genetic characteristics in a Han Chinese AD cohort.

methodsDetailed clinical assessment was applied to all the patients. We screened amyloid precursor protein (APP), PSEN1, PSEN2, and microtubule-associated protein tau (MAPT) genes were assessed in 83 sporadic AD patients by Sanger sequencing. A total of 25 probands from families with AD were subjected to next-generation sequencing on 53 dementia-associated genes to capture the target region, and Sanger sequencing was used to detect the variants in the DNA sequence.

resultsPSEN1 p.L226R was found in an early-onset AD (EOAD) family characterized by language impairment at disease onset, a novel probably pathogenetic variant (p.D534H) was identified in a frontal-temporal dementia gene, TANK-binding kinase 1 (TBK1) with a typical AD phenotype in a late-onset AD (LOAD) family, and a PSEN2p.H169N mutation and two benign MAPT (p.Q230R and p.V48L) mutations were detected in three EOAD patients.

conclusionsThus, five variants were identified in a Han Chinese cohort. In the present study, a novel, probably damaging FTLD gene TBK1variant with a typical AD phenotype was detected. Also, the phenotypic characteristics of PSEN1 p.L226R, a PSEN2pathogenic mutation, and two likely benign MAPT variants were described. Hence, screening for mutations in other dementia genes could be further explored in clinically diagnosed AD patients.

Indexed as

MutationAgedAlzheimer DiseaseAmyloid beta-Protein PrecursorAsian PeopleChinaDNA Mutational AnalysisFemaleHumansMaleMiddle AgedPresenilin-1Presenilin-2tau ProteinsAmyloid beta-Protein PrecursorPresenilin-1Presenilin-2tau ProteinsAlzheimer's diseasefrontotemporal dementiagene mutationMAPTPSEN1PSEN2TBK1

Identifiers

PMID30549411
PMCPMC6346667
OpenAlexW2903819877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.